Adult-type soft tissue sarcomas in pediatric-age patients: experience at the Istituto Nazionale Tumori in Milan.
暂无分享,去创建一个
Andrea Ferrari | Luigi Mariani | Maura Massimino | Lorenza Gandola | L. Mariani | A. Ferrari | A. Gronchi | M. Massimino | P. Collini | R. Luksch | C. Meazza | F. Spreafico | Michela Casanova | Alessandro Gronchi | Cristina Meazza | Paola Collini | L. Gandola | G. Cefalo | M. Terenziani | M. Casanova | S. Catania | Roberto Luksch | F. Fossati‐Bellani | Filippo Spreafico | Franca Fossati-Bellani | Graziella Cefalo | Monica Terenziani | Serena Catania
[1] R. Benjamin,et al. High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] M Bonetti,et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] C. Arndt,et al. Nonrhabdomyosarcoma Soft Tissue Sarcomas in Children: The Mayo Clinic Experience , 2000, Clinical orthopaedics and related research.
[4] B. Rao,et al. Nonrhabdomyosarcoma in children: prognostic factors influencing survival. , 1993, Seminars in surgical oncology.
[5] D. Cox. Regression Models and Life-Tables , 1972 .
[6] R. DeMatteo. The GIST of targeted cancer therapy: A tumor (Gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571) , 2002, Annals of Surgical Oncology.
[7] S. Spunt,et al. Soft tissue sarcomas of childhood. , 2004, Cancer treatment reviews.
[8] A. Santoro,et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] C. Antonescu,et al. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] J. Crowley,et al. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Jonathan J. Lewis,et al. Histopathologic Type: An Independent Prognostic Factor in Primary Soft Tissue Sarcoma of the Extremity? , 2003, Annals of Surgical Oncology.
[12] J. Edmonson,et al. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] W. J. Conover,et al. Practical Nonparametric Statistics , 1972 .
[14] A. Pappo,et al. Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group Study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] D. Crowther. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data , 1997, The Lancet.
[16] A. Pappo,et al. Nonrhabdomyosarcoma soft tissue sarcomas in children: is age at diagnosis an important variable? , 2000, Journal of pediatric surgery.
[17] W. Enneking,et al. A System for the Surgical Staging of Musculoskeletal Sarcoma , 1980, Clinical orthopaedics and related research.
[18] J. Coindre,et al. Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system , 1984, International journal of cancer.
[19] S. Steinberg,et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] M. Carli,et al. Summary of the International Symposium on Childhood Non-Rhabdomyosarcoma Soft-Tissue Sarcomas, Padua, Italy, February 10-12, 1994. , 1996, Medical and pediatric oncology.
[21] T. Merchant,et al. Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] T. Merchant,et al. Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] A. Pappo,et al. A pilot study of vincristine, ifosfamide, and doxorubicin in the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomas. , 1998, Medical and pediatric oncology.
[24] D. Green,et al. Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group study. , 1998, Medical and pediatric oncology.
[25] F. Collin,et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] D H Leung,et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] V. Bramwell. Adjuvant chemotherapy for adult soft tissue sarcoma: Is there a standard of care? , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] M. Munsell,et al. Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] E. Gehan,et al. The intergroup rhabdomyosarcoma study‐I. A final report , 1988, Cancer.
[30] G. Rosen,et al. Synovial sarcoma. Uniform response of metastases to high dose ifosfamide , 1994, Cancer.
[31] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .